Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has ...
The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a large DNA payload into T cells in vivo.
A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells ...
CAR T-cell therapy has revolutionized treatment for many blood cancers. However, the benefits of its use in the early stages of care remain uncertain. Chimeric antigen receptor (CAR) T-cell therapy ...
Consider the case of patient WB, a 79-year-old male with recurrent diffuse large B cell lymphoma. He was referred for ...
A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results